Commonwealth Equity Services’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
Other funds holding INFI
BI
SFM
CC
E
Commonwealth Equity Services's INFI Position: Q1 2023 in Review
Commonwealth Equity Services sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2023, closing a stake of 18,771 shares — an estimated $10K sold.
Commonwealth Equity Services first reported a position in INFI in Q1 2022 and held it in 2 quarters. The position peaked at $13K in Q1 2022. 53 funds tracked by Wall St. Rank hold INFI as of Q1 2023.
- Commonwealth Equity Services reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Commonwealth Equity Services sold 18,771 Infinity Pharmaceuticals, Inc. shares in Q1 2023, an estimated $10K.
- Commonwealth Equity Services first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2022 and held it in 2 quarters.
- Commonwealth Equity Services's Infinity Pharmaceuticals, Inc. position peaked at $13K in Q1 2022.
- 53 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2023.
Based on Commonwealth Equity Services's 13F filing for Q1 2023, filed 11 May 2023.